MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 263 filers reported holding MYRIAD GENETICS INC in Q1 2018. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $308,000 | +5.1% | 9,542 | -0.5% | 0.00% | – |
| Q2 2021 | $293,000 | +12.7% | 9,594 | -47.2% | 0.00% | – |
| Q1 2020 | $260,000 | -36.7% | 18,155 | +20.2% | 0.00% | -100.0% |
| Q4 2019 | $411,000 | +30.5% | 15,106 | +59.1% | 0.00% | – |
| Q1 2019 | $315,000 | +43.2% | 9,493 | +25.4% | 0.00% | – |
| Q4 2018 | $220,000 | -30.8% | 7,570 | +9.4% | 0.00% | – |
| Q3 2018 | $318,000 | +46.5% | 6,919 | +9.3% | 0.00% | – |
| Q4 2017 | $217,000 | -34.0% | 6,331 | -30.4% | 0.00% | -100.0% |
| Q3 2017 | $329,000 | -4.9% | 9,097 | -10.6% | 0.00% | -50.0% |
| Q4 2014 | $346,000 | -11.3% | 10,173 | +0.7% | 0.00% | 0.0% |
| Q3 2014 | $390,000 | -66.1% | 10,107 | -65.8% | 0.00% | -71.4% |
| Q2 2014 | $1,149,000 | +143.4% | 29,532 | +68.3% | 0.01% | +75.0% |
| Q2 2013 | $472,000 | – | 17,552 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 6,635,000 | $106,425 | 3.51% |
| Glenview Capital Management | 3,783,982 | $60,695,071 | 1.37% |
| AMH Equity Ltd | 47,285 | $758,451 | 0.83% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,973,312 | $31,651,924 | 0.75% |
| EARNEST PARTNERS LLC | 3,473,281 | $55,711,427 | 0.32% |
| AIMZ Investment Advisors, LLC | 40,985 | $657,399 | 0.29% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 280,767 | $4,503,503 | 0.13% |
| Beverly Hills Private Wealth, LLC | 19,687 | $315,779 | 0.09% |
| Artisan Partners Limited Partnership | 2,537,147 | $40,695,838 | 0.07% |
| Jump Financial, LLC | 84,924 | $1,362,181 | 0.05% |